InvestorsHub Logo
Followers 840
Posts 120475
Boards Moderated 18
Alias Born 09/05/2002

Re: DewDiligence post# 728

Thursday, 07/22/2021 9:26:57 AM

Thursday, July 22, 2021 9:26:57 AM

Post# of 814
ABT 2Q21 Results by Business Segment


%Corp YoY Growth
Segment Sales (const currency)

Medical devices* 36% +45%
Diagnostics 32% +57%
Nutrition 21% +10%
Drugs† 12% +15%

2Q21 COVID-19 diagnostics sales were $1.5B, 46% of total 2Q21 diagnostics sales.

65% of overall corporate sales were ex-US.

*Includes diabetes care.
†Branded generics in emerging markets.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABT News